• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

压力作为多发性硬化症发病或复发的风险因素:系统评价。

Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.

机构信息

Immunogenetic Laboratory, Department of Neurology, Aeginition Hospital, National and Kapodistrian University Medical School, Athens, Greece. artemiad @ med.uoa.gr

出版信息

Neuroepidemiology. 2011;36(2):109-20. doi: 10.1159/000323953. Epub 2011 Feb 17.

DOI:10.1159/000323953
PMID:21335982
Abstract

BACKGROUND

Stress has been considered a triggering factor for multiple sclerosis (MS) since the description of the disease by Jean-Martin Charcot. Until our times, many published studies have supported that both MS onset and relapse could be predisposed by psychological stress. This review aims to synthesize existing knowledge of the relationship between psychological stress and MS onset and relapse, focusing mainly on the quality of observational studies.

METHODS

We hand-searched MEDLINE with the terms 'stress and multiple sclerosis', using English language restrictions, from January 1980 to November 2010. We included only observational longitudinal studies. The Newcastle-Ottawa scale proposed by the Cochrane Collaboration was used for assessing the quality of the observational studies.

RESULTS

Seventeen publications were analyzed, 5 for MS onset (1 cohort and 4 case-control studies) and 12 for MS relapse (9 cohort and 3 case-control studies). We found a marked heterogeneity in stress measurement that mostly targeted the environmental approach to stress. Only 2 publications used radiological criteria for MS relapse. Quality issues were identified mainly for comparability, meaning that studies failed to control adequately for various triggering and psychosocial factors in the stress-MS relationship. Also, selection and blinding problems were identified in most case-control studies. All studies, with only 2 exceptions, resulted in favor of the stress-MS relationship, but due to marked stress measurement heterogeneity, no secure conclusions could be drawn.

CONCLUSIONS

Future studies should incorporate a multidisciplinary approach to stress measurement and radiological criteria for MS. We further encourage researchers to test the effect of early life stress and stress management techniques on the clinical course of the disease.

摘要

背景

自让·马丁·夏科(Jean-Martin Charcot)描述多发性硬化症(MS)以来,压力一直被认为是多发性硬化症的触发因素。直到现在,许多已发表的研究都支持心理压力可能导致多发性硬化症的发作和复发。本综述旨在综合现有知识,探讨心理压力与多发性硬化症发作和复发之间的关系,主要关注观察性研究的质量。

方法

我们使用英语语言限制,从 1980 年 1 月到 2010 年 11 月,手工检索了 MEDLINE 中的“stress and multiple sclerosis”一词。我们只纳入了观察性纵向研究。采用 Cochrane 协作组提出的纽卡斯尔-渥太华量表来评估观察性研究的质量。

结果

共分析了 17 篇文献,其中 5 篇用于多发性硬化症的发病(1 项队列研究和 4 项病例对照研究),12 篇用于多发性硬化症的复发(9 项队列研究和 3 项病例对照研究)。我们发现压力测量方法存在明显的异质性,主要针对环境应激方法。只有 2 篇文献使用放射学标准来定义多发性硬化症的复发。主要存在质量问题的是可比性,这意味着研究未能充分控制压力-多发性硬化症关系中的各种触发因素和心理社会因素。此外,在大多数病例对照研究中也存在选择和盲法问题。除了 2 项研究外,所有研究都支持压力与多发性硬化症之间的关系,但由于压力测量方法存在明显的异质性,因此无法得出确切的结论。

结论

未来的研究应采用多学科方法来测量压力,并采用放射学标准来定义多发性硬化症。我们进一步鼓励研究人员测试早期生活压力和压力管理技术对疾病临床病程的影响。

相似文献

1
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.压力作为多发性硬化症发病或复发的风险因素:系统评价。
Neuroepidemiology. 2011;36(2):109-20. doi: 10.1159/000323953. Epub 2011 Feb 17.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.对首次出现提示多发性硬化症临床发作的患者使用疾病修饰药物进行治疗。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD012200. doi: 10.1002/14651858.CD012200.pub2.
6
Siponimod for multiple sclerosis.西尼莫德用于多发性硬化症。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013647. doi: 10.1002/14651858.CD013647.pub2.
7
Memory rehabilitation for people with multiple sclerosis.针对多发性硬化症患者的记忆康复治疗。
Cochrane Database Syst Rev. 2016 Mar 23;3:CD008754. doi: 10.1002/14651858.CD008754.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Yoga for epilepsy.用于癫痫治疗的瑜伽
Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD001524. doi: 10.1002/14651858.CD001524.pub3.

引用本文的文献

1
Evaluation of salivary nitric oxide levels and anxiety in multiple sclerosis patients, with and without Xerostomia: correlation with clinical variables.评估有无口干症的多发性硬化症患者的唾液一氧化氮水平和焦虑情况:与临床变量的相关性
BMC Oral Health. 2025 Apr 8;25(1):507. doi: 10.1186/s12903-025-05878-7.
2
Lifetime stressors relate to invisible symptoms of multiple sclerosis.终生应激源与多发性硬化症的隐匿症状相关。
Explor Neuroprotective Ther. 2024;4(2):158-171. doi: 10.37349/ent.2024.00077. Epub 2024 Apr 22.
3
Motivators and barriers for smoking cessation in people with multiple sclerosis: a qualitative study to inform the design of a tailored intervention.
多发性硬化症患者戒烟的动机与障碍:一项为定制干预措施设计提供依据的定性研究
BMC Public Health. 2024 Dec 17;24(1):3402. doi: 10.1186/s12889-024-20998-5.
4
Relevance of Saliva Analyses in Terms of Etiological Factors, Biomarkers, and Indicators of Disease Course in Patients with Multiple Sclerosis-A Review.唾液分析在多发性硬化症患者病因学因素、生物标志物及疾病进程指标方面的相关性——综述
Int J Mol Sci. 2024 Nov 22;25(23):12559. doi: 10.3390/ijms252312559.
5
Resilience, Mental Health, Sleep, and Smoking Mediate Pathways Between Lifetime Stressors and Multiple Sclerosis Severity.心理韧性、心理健康、睡眠和吸烟介导了终生应激源与多发性硬化症严重程度之间的途径。
Sclerosis. 2024 Dec;2(4):341-354. doi: 10.3390/sclerosis2040022. Epub 2024 Oct 30.
6
Subclinical imaging activity in multiple sclerosis patients during war-related psychological stress.战争相关心理压力期间多发性硬化症患者的亚临床成像活动
Ann Clin Transl Neurol. 2025 Jan;12(1):17-25. doi: 10.1002/acn3.52241. Epub 2024 Nov 6.
7
Oral State and Salivary Cortisol in Multiple Sclerosis Patients.多发性硬化症患者的口腔状态与唾液皮质醇
Biomedicines. 2024 Oct 8;12(10):2277. doi: 10.3390/biomedicines12102277.
8
Patient-reported outcome measures for the assessment of stress in neurological patients: An integrative review.用于评估神经科患者压力的患者报告结局指标:一项综合综述。
Int J Nurs Stud Adv. 2023 Dec 15;6:100172. doi: 10.1016/j.ijnsa.2023.100172. eCollection 2024 Jun.
9
Resilience, mental health, sleep, and smoking mediate pathways between lifetime stressors and Multiple Sclerosis severity.心理韧性、心理健康、睡眠和吸烟在终生应激源与多发性硬化症严重程度之间的中介途径中起作用。
medRxiv. 2024 Feb 7:2024.02.06.24302405. doi: 10.1101/2024.02.06.24302405.
10
Association Between Diseases and Symptoms Diagnosed in Primary Care and the Subsequent Specific Risk of Multiple Sclerosis.初级保健中诊断的疾病和症状与多发性硬化症后续特定风险之间的关联。
Neurology. 2023 Dec 12;101(24):e2497-e2508. doi: 10.1212/WNL.0000000000207981. Epub 2023 Nov 29.